Want this question answered?
jhdfwegyuhe cde7r uf;nbigdjkyoiaskiojfn vbgfkvlsd;ss;'
To start a snow removal business, you will need some employees and a snow plow or shovel, depending on how big of a snow removal service you'd like your business to become. You will also need a business license and perhaps insurance.
Any one of several species of flatfishes of the genus Solea and allied genera of the family Soleidae, especially the common European species (Solea vulgaris), which is a valuable food fish., Any one of several American flounders somewhat resembling the true sole in form or quality, as the California sole (Lepidopsetta bilineata), the long-finned sole (Glyptocephalus zachirus), and other species., The bottom of the foot; hence, also, rarely, the foot itself., The bottom of a shoe or boot, or the piece of leather which constitutes the bottom., The bottom or lower part of anything, or that on which anything rests in standing., The bottom of the body of a plow; -- called also slade; also, the bottom of a furrow., The horny substance under a horse's foot, which protects the more tender parts., The bottom of an embrasure., A piece of timber attached to the lower part of the rudder, to make it even with the false keel., The seat or bottom of a mine; -- applied to horizontal veins or lodes., To furnish with a sole; as, to sole a shoe., Being or acting without another; single; individual; only., Single; unmarried; as, a feme sole.
Merck & Co. is buying Schering-Plough Corp. for $41.1 billion.
There are several reasons. First, everyone else is--Pfizer just bought Wyeth, for instance. Second, the two companies have complimentary portfolios of prescription medicines, many of which are about ready to come off patent, and they don't have a massive amount of new products in the pipeline. Drugs are very expensive to bring to market, and they're starting to run out of new diseases to develop drugs to treat. Merck benefits here because Schering-Plough has a lot more drugs that aren't about to go off-patent than Merck does, and Schering-Plough has animal health and consumer health divisions Merck needs. Schering-Plough benefits because Merck is exceptionally well-funded and they have a vaccine business S-P needs. All is not happiness and joy, though; the merger is going to shed about 15,000 workers.
There are several reasons. First, everyone else is--Pfizer just bought Wyeth, for instance. Second, the two companies have complimentary portfolios of prescription medicines, many of which are about ready to come off patent, and they don't have a massive amount of new products in the pipeline. Drugs are very expensive to bring to market, and they're starting to run out of new diseases to develop drugs to treat. Merck benefits here because Schering-Plough has a lot more drugs that aren't about to go off-patent than Merck does, and Schering-Plough has animal health and consumer health divisions Merck needs. Schering-Plough benefits because Merck is exceptionally well-funded and they have a vaccine business S-P needs. All is not happiness and joy, though; the merger is going to shed about 15,000 workers.
pension accounts
he doesn't have one
What was the price of Schering Plough Stock in 1994 and 1995?
Schering Plough corporation are a pharmaceutical company. They produce drugs to combat allergies with the most well known drugs they produce being Claritin and Clarinex.
Your mom Happened hahahaha
with a plow...
a plow
A plow.
A plow that a horse pulls.